GCI Health Brussels

Tweet this page
<
2022
2023
>
Registration as it was on 04 Oct 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

400,000€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

2.25 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    GCI Health Brussels

    EU Transparency Register

    685884647362-97 First registered on 10 Aug 2022

    Goals / Remit

    GCI Health is a global integrated healthcare communications and public affairs agency Inspired by People. We share our clients’ desire to improve the health of all people around the world and work tirelessly to contribute to their ambitious goals. Our approach to communications is rooted in looking at all stakeholders – patients, caregivers, healthcare providers, policy makers, reporters and payers – as people with distinct perspectives that shape how they think about health. We create breakthrough, people-driven programs that drive tangible results for our clients and the people they serve. And we carefully curate a culture that is catalyzed by the belief that people should be as successful in their personal lives as they are in their professional ones.

    Main EU files targeted

    • EU pharmaceutical strategy
    • Europe beating cancer plan
    • Vaccine strategy
    • European Health Data Space
    • One Health - AMR
    • IP
    • EU4Health Programme
    • EU Recovery Plans
    • EU strategic autonomy
    • European Health Union package
    • Pandemic preparedness
    • European Plan for Rare Diseases by 2030 (pushed for by French Presidency)
    • Important Projects of Common European Interest for the Health industry
    • Revision of the Blood, Tissues and Cells Directive
    • European Green Deal

    Address

    Head Office
    Square de Meeus 37
    Bruxelles 1000
    BELGIUM
    EU Office
    Square de Meeus 37
    Bruxelles 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    100%2
    25%1

    Lobbyists (Full time equivalent)

    2.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 04 Oct 2022

    Name Start date End Date
    Dorothea DALIG 28 Jul 2023 26 Jul 2024
    Ms Dorothea DALIG 28 Jul 2023 15 Apr 2024
    Martina ANDREONI 05 Jul 2023 04 Jul 2024
    Paraskevi PALAIOLOGOU 21 Jun 2023 20 Jun 2024
    Mr Thomas GILLET 08 Oct 2022 05 Oct 2023

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Professional consultancies

  • Networking

    Affiliation

    • EPACA epaca.org
    • PAC pac.org

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Advances interests of their clients

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    400,000€

    Major contributions in closed year

    None declared

    Clients for closed financial year

    Clients list
    NameProposalAmount
    SANOFI Europe's Beating Cancer Plan EU Pharmaceutical Strategy 400,000€ - 499,999€

    Clients for current financial year

    Clients list
    Name
    seattle genetics
    SANOFI
    Pfizer

    Other financial info

    Sanofi estimated value 2022 full year between 600,000 to 700,000 euro, Pfizer estimated 2022 revenue ~50,000 euro, Seattle Genetics estimated revenue 10,000 euros.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    • Stakeholder engagement
    • Disease awareness
    • Grassroots mobilization
    • Multicultural marketing
    • Advocacy Relations
    • Public Affairs and Policy (e.g., events, campaigns, research, publications, briefings, information sharing, policymaker engagement, stakeholder relationship building etc.)

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard